Topic
Jak Inhibitor
Topic counter · /jak inhibitor
Jak Inhibitor
1 piece on this counter
· 2 min
Ruxolitinib Cream Hit 79% Response Rate in HS Phase 2 Trial
A phase 2 trial found ruxolitinib 1.5% cream (Opzelura) produced a 79% response rate in mild to moderate hidradenitis suppurativa. Phase 3 trials are now under…
